Lobbying client

ANAVEX LIFE SCIENCES

Biopharma innovator

Filings
7
Filed by
1
Reported in-house
—
Reported by firms
$280,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2025 to 2026

Filings

2 filings for 2026, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2026
FORBES-TATE — reported
1st Quarter - Report
1st Quarter 2026
FORBES-TATE $40,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
FORBES-TATE 6 $280,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 6

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.